Significance of CD47 expression in endometrial carcinoma

Objectives: CD47 is a membrane protein that belongs to the immunoglobulin superfamily and regulates macrophage phagocytosis negatively. As CD47 expression at the cancer cell membrane would inhibit the phagocytic activity of immune cells, it is connected to an unfavorable prognosis in leukemia and ma...

Full description

Bibliographic Details
Main Authors: Nurhan Sahin, Ganime Coban, Nurcan Unver, Dilek S Arici, Gokhan Kilic, Ozlem Toluk
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=4;spage=856;epage=859;aulast=Sahin
_version_ 1797963522838102016
author Nurhan Sahin
Ganime Coban
Nurcan Unver
Dilek S Arici
Gokhan Kilic
Ozlem Toluk
author_facet Nurhan Sahin
Ganime Coban
Nurcan Unver
Dilek S Arici
Gokhan Kilic
Ozlem Toluk
author_sort Nurhan Sahin
collection DOAJ
description Objectives: CD47 is a membrane protein that belongs to the immunoglobulin superfamily and regulates macrophage phagocytosis negatively. As CD47 expression at the cancer cell membrane would inhibit the phagocytic activity of immune cells, it is connected to an unfavorable prognosis in leukemia and malignancies of various solid organs. Materials and Methods: In this study, retrospectively evaluated 72 patients who had been diagnosed with endometrial carcinoma at Pathology Department and had undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH + BSO) and/or lymphadenectomy. CD47 expression was evaluated in tumorous and nontumor areas in all patients considering cytoplasmic and membranous brown staining in cells. The proportion of expression was evaluated as well as the intensity and an “h score” was obtained. This score was compared with known prognostic parameters. Results: CD47 expressions showed a statistically significant correlation with tumor grade (P < 0.05); however, no significant relationship was observed with myometrial invasion depth and lymph vascular invasion status (P = 0.923 and P = 0.754, respectively). Conclusions: As with other tumors, anti-CD47 antibody may be an alternative treatment option in patients with high-grade endometrial carcinoma.
first_indexed 2024-04-11T01:29:41Z
format Article
id doaj.art-ba01c69a21cb4abfa0605f0fc7234b60
institution Directory Open Access Journal
issn 0377-4929
language English
last_indexed 2024-04-11T01:29:41Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj.art-ba01c69a21cb4abfa0605f0fc7234b602023-01-03T09:56:32ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292022-01-0165485685910.4103/ijpm.ijpm_223_21Significance of CD47 expression in endometrial carcinomaNurhan SahinGanime CobanNurcan UnverDilek S AriciGokhan KilicOzlem TolukObjectives: CD47 is a membrane protein that belongs to the immunoglobulin superfamily and regulates macrophage phagocytosis negatively. As CD47 expression at the cancer cell membrane would inhibit the phagocytic activity of immune cells, it is connected to an unfavorable prognosis in leukemia and malignancies of various solid organs. Materials and Methods: In this study, retrospectively evaluated 72 patients who had been diagnosed with endometrial carcinoma at Pathology Department and had undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH + BSO) and/or lymphadenectomy. CD47 expression was evaluated in tumorous and nontumor areas in all patients considering cytoplasmic and membranous brown staining in cells. The proportion of expression was evaluated as well as the intensity and an “h score” was obtained. This score was compared with known prognostic parameters. Results: CD47 expressions showed a statistically significant correlation with tumor grade (P < 0.05); however, no significant relationship was observed with myometrial invasion depth and lymph vascular invasion status (P = 0.923 and P = 0.754, respectively). Conclusions: As with other tumors, anti-CD47 antibody may be an alternative treatment option in patients with high-grade endometrial carcinoma.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=4;spage=856;epage=859;aulast=Sahincd47endometrial carcinomaimmunotherapymonoclonal antibody
spellingShingle Nurhan Sahin
Ganime Coban
Nurcan Unver
Dilek S Arici
Gokhan Kilic
Ozlem Toluk
Significance of CD47 expression in endometrial carcinoma
Indian Journal of Pathology and Microbiology
cd47
endometrial carcinoma
immunotherapy
monoclonal antibody
title Significance of CD47 expression in endometrial carcinoma
title_full Significance of CD47 expression in endometrial carcinoma
title_fullStr Significance of CD47 expression in endometrial carcinoma
title_full_unstemmed Significance of CD47 expression in endometrial carcinoma
title_short Significance of CD47 expression in endometrial carcinoma
title_sort significance of cd47 expression in endometrial carcinoma
topic cd47
endometrial carcinoma
immunotherapy
monoclonal antibody
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=4;spage=856;epage=859;aulast=Sahin
work_keys_str_mv AT nurhansahin significanceofcd47expressioninendometrialcarcinoma
AT ganimecoban significanceofcd47expressioninendometrialcarcinoma
AT nurcanunver significanceofcd47expressioninendometrialcarcinoma
AT dileksarici significanceofcd47expressioninendometrialcarcinoma
AT gokhankilic significanceofcd47expressioninendometrialcarcinoma
AT ozlemtoluk significanceofcd47expressioninendometrialcarcinoma